Astrazeneca PLC

Astrazeneca PLC has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Entasis Therapeutics Holdings Inc., PhaseBio Pharmaceuticals Inc and Viela Bio, Inc. The record holds 8 filings, for trades running from 1 December 2017 to 19 December 2019.

On the open market, the record shows 4 purchases worth €13.2M and 1 sale worth €9.0M. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2020 alone, the filings show 1 purchase and no sales.

The median purchase comes to €3.2M. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 7 February 2020 with an open-market purchase in Aevi Genomic Medicine, LLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.